Evidence map›Paper›PMID 42353358›Full record

ArticleInternational journal of molecular sciences2026

Correction: Shyamsunder et al. THZ531 Induces a State of BRCAness in Multiple Myeloma Cells: Synthetic Lethality with Combination Treatment of THZ 531 with DNA Repair Inhibitors.

Pavithra Shyamsunder, Shree Pooja Sridharan, Vikas Madan, Pushkar Dakle, Cao Zeya, Deepika Kanojia, Wee-Joo Chng, S Tiong Ong, H Phillip Koeffler

Abstract readPublished Erratum
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Pavithra ShyamsunderCancer Science Institute of Singapore, National University of Singapore, Singapore 117599, Singapore.ORCID 0000-0003-1792-312X
Shree Pooja SridharanCancer Science Institute of Singapore, National University of Singapore, Singapore 117599, Singapore.
Vikas MadanCancer Science Institute of Singapore, National University of Singapore, Singapore 117599, Singapore.
Pushkar DakleCancer Science Institute of Singapore, National University of Singapore, Singapore 117599, Singapore.
Cao ZeyaCancer Science Institute of Singapore, National University of Singapore, Singapore 117599, Singapore.
Deepika KanojiaCancer Science Institute of Singapore, National University of Singapore, Singapore 117599, Singapore.
Wee-Joo ChngCancer Science Institute of Singapore, National University of Singapore, Singapore 117599, Singapore.ORCID 0000-0003-2578-8335
S Tiong OngCancer & Stem Cell Biology Programme, Duke-NUS Medical School, Singapore 169857, Singapore.
H Phillip KoefflerCancer Science Institute of Singapore, National University of Singapore, Singapore 117599, Singapore.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the original publication [...].

Identifiers

PMID42353358
PMCPMC13299451

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.